|Articles|January 20, 2023
T Cell expansion in the DASbox® Mini Bioreactor System
Author(s)Eppendorf
This application note examines the suitability of BioBLU® 0.3c Single-Use Bioreactors and the DASbox Mini Bioreactor System in the long-term expansion of CD4+ T cells.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
2
Transforming Clinical Bioanalysis for Manufacturing Scalability
3
Mastering Phase-Appropriate Characterization for Biologics Approval
4
Maximizing Productivity and Scalability with Perfusion Technology
5
